Ikarian Capital, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Ikarian Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $617,394 - $900,243	-59,422 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $676,816 - $964,419	59,422 New	59,422 $677,000
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $677,829 - $978,801	-51,273 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $834,000 - $1.2 Million	-50,000 Reduced 49.37%	51,273 $949,000
Q4 2020 Feb 12, 2021	SELL	$14.8 - $21.15 $3.58 Million - $5.11 Million	-241,725 Reduced 70.47%	101,273 $1.79 Million
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $4.79 Million - $8.03 Million	314,724 Added 1113.12%	342,998 $5.25 Million
Q2 2020 Aug 14, 2020	SELL	$15.08 - $26.0 $4.99 Million - $8.6 Million	-330,650 Reduced 92.12%	28,274 $720,000
Q1 2020 May 15, 2020	BUY	$11.0 - $19.76 $3.95 Million - $7.09 Million	358,924 New	358,924 $5.56 Million

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.